查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2126370

診斷耗材市場－策略分析與預測（2026-2035）

Diagnostic Consumables Market - Strategic Insights and Forecasts (2026-2035)
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計診斷耗材市場將從 2026 年的 952 億美元成長到 2035 年的 1,943 億美元，複合年成長率為 8.2%。

診斷耗材市場正經歷重大變革，其驅動力來自精準醫療、分散式檢查和檢查室自動化模式轉移。這項市場演變的特點是，人們日益認知到試劑、檢測盒、檢體採集裝置和檢查室塑膠等耗材是診斷檢測持續收入的基礎，透過更換和常規採購週期，這些耗材貢獻了約 60% 至 75% 的市場總收入。隨著感染疾病和慢性病的盛行率持續上升，以及醫療機構將早期疾病檢測和監測置於優先地位，全球醫療系統中進行的診斷檢測數量正在增加。分子診斷、免疫診斷和自動化檢測流程的整合正在加速對高品質、可自動化的耗材的需求。透過對新一代檢測盒、多重試劑盒和永續檢測材料的大量投資，市場正在將診斷耗材確立為現代醫療服務和精準醫療的基本要素。

市場促進因素

  • 感染疾病和慢性病的盛行率上升是診斷耗材市場的主要驅動力。日益加重的全球疾病負擔導致臨床檢查室、醫院和即時檢測 (PoC) 場所對診斷檢測的需求持續成長。醫療系統正在擴大檢測能力，以支援早期診斷、疾病監測和治療監測。這項需求加劇了所有診斷技術領域對耗材的需求，從而導致診斷耗材使用量的持續成長。自動化臨床檢查室的擴展透過對自動化相容耗材的需求進一步加速了市場成長。檢查室自動化減少了人工干預並規範了工作流程，從而產生了對專為高通量分析儀和整合系統設計的耗材的需求。醫療機構正在投資檢查室現代化，以應對人手不足和不斷成長的檢測量。診斷設備製造商正在開發針對自動化工作流程最佳化的耗材，以滿足此不斷成長的需求。分子診斷的日益普及推動了對 PCR 試劑、定序盒和樣本製備產品等專用耗材的需求。隨著精準醫療和傳染病檢查的擴展，分子診斷已成為成長最快的技術領域之一。一次性耗材在分子診斷工作流程中至關重要，可確保防止污染和分析結果的可重複性。製造商正在擴展其分子診斷耗材產品線，以支援不斷成長的檢測量。對精準醫療日益成長的需求，也推動了伴隨診斷耗材和生物標記檢測材料的需求。精準醫療需要精確的分子表徵來確定治療策略，從而持續推動對高品質檢測試劑盒和試劑的需求。醫療機構正在擴展其分子檢測能力，以支持個人化治療策略。這一趨勢將支撐診斷耗材需求的長期成長。

市場限制因素

  • 診斷耗材嚴格的監管合規要求構成了市場准入壁壘，並增加了製造商的研發成本。體外診斷（IVD）耗材嚴格的品質和性能標準延長了研發時間和成本。原料和製造成本的上漲給耗材製造商的利潤率帶來了壓力，尤其是對於易受價格下跌影響的標準級產品而言。影響檢查室耗材的供應鏈中斷可能導致短缺並增加成本。人們對一次性塑膠製品的環境擔憂促使製造商推出永續的替代品，這進一步增加了研發的複雜性。

目錄

第1章執行摘要

  • 市場概述
  • 主要分析結果
  • 分析師意見
  • 策略建議

第2章 分析方法

  • 分析設計
  • 資料收集和分析方法
  • 市場規模估算
  • 預測模型
  • 先決條件和限制

第3章 全球診斷耗材市場：概述、市場規模與預測

  • 市場定義和範圍
  • 行業概覽
  • 產業變化
  • 主要市場趨勢
  • 實際成果值市場規模分析
  • 市場預測
  • 對所進行的診斷測試數量進行分析
  • 耗材使用情況分析
  • 檢查工作流程分析
  • 診斷耗材在常規臨床檢測中的作用。

第4章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰

第5章 行業情勢

  • 產業價值鏈分析
  • 定價分析
  • 還款狀態

第6章：創新趨勢

  • 新興技術
  • 產品創新
  • 永續環保的消耗品
  • 自動化耗材
  • 智慧檢體採集技術
  • 高性能診斷材料
  • 技術藍圖

第7章 監理情勢

  • 法律規範
  • 核准流程
  • 合規要求

第8章 全球診斷耗材市場：展望分析

  • 分析：依產品類型
    • 檢體採集耗材
    • 試劑盒
    • 檢測試劑盒
    • 微量吸管尖
    • 管子和容器
    • 玻片和蓋玻片
    • 微孔盤
    • 其他消耗品
  • 分析：透過診斷技術
    • 臨床化學
    • 免疫診斷
    • 分子診斷
    • 血液學
    • 微生物學
    • 組織病理學
  • 分析：依檢體類型
    • 血
    • 尿
    • 唾液
    • 組織
    • 航班
    • 其他檢體
  • 分析：最終用途：檢查室分析
    • 醫院檢查室
    • 獨立診斷檢查室
    • 學術和研究檢查室
    • 血庫
    • 臨床檢查室

第9章 全球診斷耗材市場：細分市場分析

  • 依產品類型
    • 檢體採集耗材
    • 試劑盒
    • 檢測試劑盒
    • 實驗室塑膠設備
    • 玻片和蓋玻片
    • 其他消耗品
  • 透過診斷技術
    • 臨床化學
    • 免疫診斷
    • 分子診斷
    • 血液學
    • 微生物學
    • 組織病理學
  • 透過使用
    • 感染疾病
    • 瘤
    • 循環系統
    • 內分泌學
    • 自體免疫疾病
    • 其他用途
  • 最終用戶
    • 醫院
    • 診斷檢查室
    • 學術研究機構
    • 製藥和生物技術公司
    • 血庫

第10章 全球診斷耗材市場：區域分析

  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第11章 全球診斷耗材市場：國家分析

  • 美國
  • 加拿大
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 日本
  • 中國
  • 印度
  • 韓國
  • 澳洲
  • 巴西
  • 墨西哥
  • 沙烏地阿拉伯
  • 南非

第12章 競爭格局

  • 市佔率分析
  • 策略趨勢
  • 企業合併、合作與聯盟
  • 新產品發布

第13章：公司簡介

  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Becton, Dickinson and Company
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • QIAGEN NV
  • Revvity, Inc.
  • Merck KGaA
  • Sysmex Corporation
  • Greiner Bio-One International GmbH
  • Sarstedt AG & Co. KG

第14章 全球診斷耗材市場：商業預測分析

第15章：投資與資金籌措分析

  • 創業投資趨勢
  • 政府資金
  • 研發投資

第16章：未來展望

  • 主要成長機遇
  • 未來產業趨勢
簡介目錄
Product Code: KSI-009082

The Diagnostic Consumables Market is set to reach USD 194.3 billion in 2035, growing at a CAGR of 8.2% from USD 95.2 billion in 2026.

The diagnostic consumables market is undergoing significant transformation driven by the paradigm shift toward precision medicine, decentralized testing, and laboratory automation. The market's evolution is characterized by the growing recognition that consumables-including reagents, assay kits, sample collection devices, and laboratory plastics-represent the recurring revenue backbone of diagnostic testing, generating approximately 60-75% of total market revenue through replacement and recurring procurement cycles. Healthcare systems worldwide are expanding diagnostic testing volumes as the prevalence of infectious and chronic diseases continues to rise and healthcare providers emphasize early disease detection and surveillance. The convergence of molecular diagnostics, immunodiagnostics, and automated laboratory workflows is accelerating demand for high-quality, automation-compatible consumables. The market is witnessing significant investment in next-generation assay kits, multiplex reagent cartridges, and sustainable laboratory materials, positioning diagnostic consumables as a foundational component of modern healthcare delivery and precision medicine.

Market Drivers

  • The rising prevalence of infectious and chronic diseases represents the primary driver for the diagnostic consumables market. Increasing global disease burden creates sustained demand for diagnostic testing across clinical laboratories, hospitals, and point-of-care settings. Healthcare systems are expanding testing capacity to support early diagnosis, disease surveillance, and treatment monitoring. This requirement strengthens demand for consumables across all diagnostic technology segments, resulting in sustained growth in diagnostic consumable utilization. The expansion of automated clinical laboratories is further accelerating market growth through demand for automation-compatible consumables. Laboratory automation reduces manual intervention and improves workflow standardization, creating demand for consumables designed for high-throughput analyzers and integrated systems. Healthcare providers are investing in laboratory modernization to address workforce shortages and increasing testing volumes. Diagnostic manufacturers are developing consumables optimized for automated workflows to capture growing demand. The increasing adoption of molecular diagnostics is driving demand for specialized consumables including PCR reagents, sequencing kits, and sample preparation products. Molecular diagnostics represents the fastest-growing technology segment as precision medicine and infectious disease testing expand. Single-use consumables are essential for contamination control and analytical reproducibility in molecular workflows. Manufacturers are expanding molecular consumables portfolios to support growing testing volumes. The growing demand for precision medicine is strengthening demand for companion diagnostic consumables and biomarker testing materials. Precision medicine requires accurate molecular characterization to guide therapeutic decisions, creating sustained demand for high-quality assay kits and reagents. Healthcare providers are expanding molecular testing capabilities to support personalized treatment strategies. This trend supports long-term growth in diagnostic consumable demand.

Market Restraints

  • Stringent regulatory compliance requirements for diagnostic consumables create barriers to market entry and increase development costs for manufacturers. The rigorous quality and performance standards for IVD consumables increase development timelines and costs. Rising raw material and manufacturing costs are compressing margins for consumable manufacturers, particularly for standard-grade products subject to price erosion. Supply chain disruptions affecting laboratory consumables can create shortages and increase costs. Environmental concerns regarding single-use plastic products are creating pressure for sustainable alternatives, increasing development complexity.

Technology and Product Insights

  • The technology landscape is characterized by the growing importance of automation-compatible and high-performance consumables. Immunodiagnostics and clinical chemistry continue representing major technology segments due to their extensive use in routine laboratory testing. Molecular diagnostics is expected to register the highest growth supported by PCR, NGS, companion diagnostics, and infectious disease testing. Hematology, microbiology, and histopathology continue generating substantial recurring demand for specialized laboratory consumables. The segment analysis reveals that sample collection consumables account for a significant share of the market due to their widespread use in hospitals, laboratories, and point-of-care testing. Assay kits and reagent cartridges are the fastest-growing segments owing to increasing adoption of automated analyzers and molecular diagnostic platforms. Laboratory plasticware, slides, coverslips, and other consumables continue experiencing stable demand as routine diagnostic testing volumes increase. Infectious diseases remain the largest application segment due to continuous global diagnostic testing and surveillance programs. Oncology is expected to witness the fastest growth driven by biomarker testing, companion diagnostics, and precision medicine. Hospitals and diagnostic laboratories represent the leading end-user segments, with academic and research institutes and pharmaceutical companies expanding consumable utilization. The integration of digital connectivity is becoming increasingly important as laboratories require consumables compatible with connected diagnostic ecosystems and electronic health records.

Competitive and Strategic Outlook

  • The competitive landscape features established diagnostics and life science companies alongside specialized consumable, reagent, and sample preparation providers. Thermo Fisher Scientific develops comprehensive diagnostic consumables including molecular assay kits, PCR reagents, laboratory plasticware, sample preparation products, and clinical laboratory consumables. Roche provides diagnostic consumables supporting immunodiagnostics, molecular diagnostics, tissue diagnostics, and companion diagnostics across clinical laboratories worldwide. Abbott manufactures clinical chemistry consumables, immunoassay reagents, molecular testing kits, and point-of-care consumables supporting routine diagnostic testing. Siemens Healthineers offers diagnostic consumables for clinical chemistry, immunoassays, hematology, and laboratory automation systems. Danaher supplies molecular diagnostic consumables, life science reagents, sample preparation products, and laboratory workflow solutions supporting precision diagnostics. BD develops specimen collection products, microbiology consumables, molecular diagnostic kits, and laboratory collection devices used across healthcare settings. bioMerieux specializes in microbiology consumables, molecular assay kits, culture media, and infectious disease diagnostic products. Companies are pursuing product portfolio expansion through innovation in automation-compatible consumables, multiplex assay kits, sustainable laboratory products, and consumables supporting NGS and companion diagnostics. Strategic investments in manufacturing capacity and supply chain resilience are strengthening market competitiveness. Recent key developments include Thermo Fisher Scientific expanding production capacity for molecular diagnostic consumables. Roche introduced next-generation reagent cartridges for automated molecular diagnostic platforms. Abbott launched advanced immunoassay consumables designed for high-throughput laboratory analyzers. Siemens Healthineers expanded its clinical chemistry consumable portfolio for automated laboratory systems. Danaher introduced new sample preparation consumables supporting precision molecular diagnostics.

Short Conclusion

  • The diagnostic consumables market is positioned for sustained growth driven by the convergence of diagnostic testing expansion, laboratory automation, and precision medicine. The recurring revenue nature of consumables creates stable demand fundamentals while innovation in molecular diagnostics and automation-compatible products opens new growth avenues. While challenges related to regulatory compliance, raw material costs, and environmental concerns persist, strategic investments in manufacturing capacity, supply chain resilience, and advanced product development are creating durable competitive advantages for market leaders. The long-term market outlook remains positive, with diagnostic consumables evolving into one of the largest recurring revenue segments within the global in vitro diagnostics industry, supporting early disease detection, personalized medicine, and improved patient outcomes across global healthcare systems.

Key Benefits of this Report

  • Insightful Analysis: Detailed market insights across regions, customer segments, policies, socio-economic factors, consumer preferences, and industry verticals.
  • Competitive Landscape: Understand strategic moves by key players to identify optimal market entry approaches.
  • Market Drivers and Future Trends: Assess major growth forces and emerging developments shaping the market.
  • Actionable Recommendations: Support strategic decisions to unlock new revenue streams.
  • Caters to a Wide Audience: Suitable for startups, research institutions, consultants, SMEs, and large enterprises.

What Businesses Use Our Reports For

  • Industry and market insights, opportunity assessment, product demand forecasting, market entry strategy, geographical expansion, capital investment decisions, regulatory analysis, new product development, and competitive intelligence.

Report Coverage

  • Historical data from 2021 to 2024, Base year 2025, and Forecast years from 2026 to 2035
  • Growth opportunities, challenges, supply chain outlook, regulatory framework, and trend analysis
  • Competitive positioning, strategies, and market share evaluation, and trade analysis
  • Revenue growth and forecast assessment across segments and regions
  • Company profiling including strategies, products, financials, and key developments

TABLE OF CONTENTS

1. Executive Summary

  • 1.1 Market Snapshot
  • 1.2 Key Findings
  • 1.3 Analyst Insights
  • 1.4 Strategic Recommendations

2. Research Methodology

  • 2.1 Research Design
  • 2.2 Data Collection Methodology
  • 2.3 Market Size Estimation
  • 2.4 Forecasting Model
  • 2.5 Assumptions & Limitations

3. Global Diagnostic Consumables Market Overview, Size & Forecast

  • 3.1 Market Definition & Scope
  • 3.2 Industry Overview
  • 3.3 Industry Evolution
  • 3.4 Key Market Trends
  • 3.5 Historical Market Size Analysis (2021-2025)
  • 3.6 Market Forecast (2026-2035)
  • 3.7 Diagnostic Testing Volume Analysis
  • 3.8 Consumables Utilization Analysis
  • 3.9 Laboratory Workflow Analysis
  • 3.10 Role of Diagnostic Consumables in Routine Clinical Testing

4. Market Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Market Challenges

5. Industry Landscape

  • 5.1 Industry Value Chain Analysis
  • 5.2 Pricing Analysis
  • 5.3 Reimbursement Landscape

6. Innovation Landscape

  • 6.1 Emerging Technologies
  • 6.2 Product Innovation
  • 6.3 Sustainable and Eco-Friendly Consumables
  • 6.4 Automation-Compatible Consumables
  • 6.5 Smart Sample Collection Technologies
  • 6.6 High-Performance Diagnostic Materials
  • 6.7 Technology Roadmap

7. Regulatory Landscape

  • 7.1 Regulatory Framework
  • 7.2 Approval Pathways
  • 7.3 Compliance Requirements

8. Global Diagnostic Consumables Market Landscape Analysis

  • 8.1 Analysis by Product Type
    • 8.1.1 Sample Collection Consumables
    • 8.1.2 Reagent Cartridges
    • 8.1.3 Assay Kits
    • 8.1.4 Pipette Tips
    • 8.1.5 Tubes & Containers
    • 8.1.6 Slides & Coverslips
    • 8.1.7 Microplates
    • 8.1.8 Other Consumables
  • 8.2 Analysis by Diagnostic Technology
    • 8.2.1 Clinical Chemistry
    • 8.2.2 Immunodiagnostics
    • 8.2.3 Molecular Diagnostics
    • 8.2.4 Hematology
    • 8.2.5 Microbiology
    • 8.2.6 Histopathology
  • 8.3 Analysis by Sample Type
    • 8.3.1 Blood
    • 8.3.2 Urine
    • 8.3.3 Saliva
    • 8.3.4 Tissue
    • 8.3.5 Stool
    • 8.3.6 Other Samples
  • 8.4 Analysis by End-use Laboratory
    • 8.4.1 Hospital Laboratories
    • 8.4.2 Independent Diagnostic Laboratories
    • 8.4.3 Academic & Research Laboratories
    • 8.4.4 Blood Banks
    • 8.4.5 Physician Office Laboratories

9. Global Diagnostic Consumables Market Segment Analysis (2021-2035)

  • 9.1 By Product Type
    • 9.1.1 Sample Collection Consumables
    • 9.1.2 Reagent Cartridges
    • 9.1.3 Assay Kits
    • 9.1.4 Laboratory Plasticware
    • 9.1.5 Slides & Coverslips
    • 9.1.6 Other Consumables
  • 9.2 By Diagnostic Technology
    • 9.2.1 Clinical Chemistry
    • 9.2.2 Immunodiagnostics
    • 9.2.3 Molecular Diagnostics
    • 9.2.4 Hematology
    • 9.2.5 Microbiology
    • 9.2.6 Histopathology
  • 9.3 By Application
    • 9.3.1 Infectious Diseases
    • 9.3.2 Oncology
    • 9.3.3 Cardiology
    • 9.3.4 Endocrinology
    • 9.3.5 Autoimmune Diseases
    • 9.3.6 Other Applications
  • 9.4 By End User
    • 9.4.1 Hospitals
    • 9.4.2 Diagnostic Laboratories
    • 9.4.3 Academic & Research Institutes
    • 9.4.4 Pharmaceutical & Biotechnology Companies
    • 9.4.5 Blood Banks

10. Global Diagnostic Consumables Market Geographical Analysis (2021-2035)

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia-Pacific
  • 10.4 South America
  • 10.5 Middle East & Africa

11. Global Diagnostic Consumables Market Country Analysis (2021-2035)

  • 11.1 United States
  • 11.2 Canada
  • 11.3 Germany
  • 11.4 United Kingdom
  • 11.5 France
  • 11.6 Italy
  • 11.7 Spain
  • 11.8 Japan
  • 11.9 China
  • 11.10 India
  • 11.11 South Korea
  • 11.12 Australia
  • 11.13 Brazil
  • 11.14 Mexico
  • 11.15 Saudi Arabia
  • 11.16 South Africa

12. Competitive Landscape

  • 12.1 Market Share Analysis
  • 12.2 Strategic Developments
  • 12.3 Mergers & Acquisitions, Partnerships & Collaborations
  • 12.4 Product Launches

13. Company Profiles

  • 13.1 Thermo Fisher Scientific Inc.
    • 13.1.1 Company Overview
    • 13.1.2 Financials
    • 13.1.3 Product Portfolio
    • 13.1.4 Recent Developments
  • 13.2 F. Hoffmann-La Roche Ltd.
    • 13.2.1 Company Overview
    • 13.2.2 Financials
    • 13.2.3 Product Portfolio
    • 13.2.4 Recent Developments
  • 13.3 Abbott Laboratories
    • 13.3.1 Company Overview
    • 13.3.2 Financials
    • 13.3.3 Product Portfolio
    • 13.3.4 Recent Developments
  • 13.4 Siemens Healthineers AG
    • 13.4.1 Company Overview
    • 13.4.2 Financials
    • 13.4.3 Product Portfolio
    • 13.4.4 Recent Developments
  • 13.5 Danaher Corporation
    • 13.5.1 Company Overview
    • 13.5.2 Financials
    • 13.5.3 Product Portfolio
    • 13.5.4 Recent Developments
  • 13.6 Becton, Dickinson and Company
    • 13.6.1 Company Overview
    • 13.6.2 Financials
    • 13.6.3 Product Portfolio
    • 13.6.4 Recent Developments
  • 13.7 bioMerieux
    • 13.7.1 Company Overview
    • 13.7.2 Financials
    • 13.7.3 Product Portfolio
    • 13.7.4 Recent Developments
  • 13.8 Bio-Rad Laboratories, Inc.
    • 13.8.1 Company Overview
    • 13.8.2 Financials
    • 13.8.3 Product Portfolio
    • 13.8.4 Recent Developments
  • 13.9 Agilent Technologies, Inc.
    • 13.9.1 Company Overview
    • 13.9.2 Financials
    • 13.9.3 Product Portfolio
    • 13.9.4 Recent Developments
  • 13.10 QIAGEN N.V.
    • 13.10.1 Company Overview
    • 13.10.2 Financials
    • 13.10.3 Product Portfolio
    • 13.10.4 Recent Developments
  • 13.11 Revvity, Inc.
    • 13.11.1 Company Overview
    • 13.11.2 Financials
    • 13.11.3 Product Portfolio
    • 13.11.4 Recent Developments
  • 13.12 Merck KGaA
    • 13.12.1 Company Overview
    • 13.12.2 Financials
    • 13.12.3 Product Portfolio
    • 13.12.4 Recent Developments
  • 13.13 Sysmex Corporation
    • 13.13.1 Company Overview
    • 13.13.2 Financials
    • 13.13.3 Product Portfolio
    • 13.13.4 Recent Developments
  • 13.14 Greiner Bio-One International GmbH
    • 13.14.1 Company Overview
    • 13.14.2 Financials
    • 13.14.3 Product Portfolio
    • 13.14.4 Recent Developments
  • 13.15 Sarstedt AG & Co. KG
    • 13.15.1 Company Overview
    • 13.15.2 Financials
    • 13.15.3 Product Portfolio
    • 13.15.4 Recent Developments

14. Global Diagnostic Consumables Market Commercial Forecast Analysis

  • 14.1 Sample Collection Consumables
  • 14.2 Assay Kits
  • 14.3 Reagent Cartridges
  • 14.4 Laboratory Plasticware
  • 14.5 Slides & Coverslips
  • 14.6 Microplates
  • 14.7 Tubes & Containers
  • 14.8 Other Diagnostic Consumables

15. Investment & Funding Analysis

  • 15.1 Venture Capital Trends
  • 15.2 Government Funding
  • 15.3 R&D Investments

16. Future Outlook

  • 16.1 Key Growth Opportunities
  • 16.2 Future Industry Trends